Valproate-Induced Hyperammonemic Encephalopathy
References
- Segura-Bruna N Rodriguez-Campello A Puente V Roquer J Valproate-induced hyperammonemic encephalopathy Acta Neurol Scand 2006 Jul 114 1 1 7 10.1111/j.1600-0404.2006.00655.x 16774619
- Beghi E Bizzi A Codegoni AM Trevisan D Torri W Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy Epilepsia 1990 May-Jun 31 3 346 352 10.1111/j.1528-1157.1990.tb05387.x 2111771
- König SA Siemes H Bläker F Boenigk E Gross-Selbeck G Hanefeld F Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities Epilepsia 1994 Sep-Oct 35 5 1005 1015 10.1111/j.1528-1157.1994.tb02546.x 7925143
-
Bryant
AE
3rd Dreifuss FE Valproic acid hepatic fatalities. III. U.S. experience since 1986 Neurology 1996 Feb 46 2 465 469 10.1212/WNL.46.2.465 8614514 - Aldenkamp A Vigevano F Arzimanoglou A Covanis A Role of valproate across the ages. Treatment of epilepsy in children Acta Neurol Scand Suppl 2006 184 1 13 10.1111/j.1600-0404.2006.00666.x 16776492
-
Wheless
JW
J Child Neurol
2005
20
Suppl 1 S34 S35 10.1177/08830738050200010601 - Golden AS Haut SR Moshé SL Nonepileptic uses of antiepileptic drugs in children and adolescents Pediatr Neurol 2006 Jun 34 6 421 432 10.1016/j.pediatrneurol.2005.08.017 16765818
DOI: https://doi.org/10.15844/pedneurbriefs-20-7-5 | Journal eISSN: 2166-6482
Language: English
Page range: 52 - 53
Published on: Jul 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.